Takeda Pharmaceutical Co Ltd (NYSE:TAK) Q3 2021 Earnings Conference Call February 4, 2021 6:00 AM ET Company Participants Christopher O'Reilly - Global Head, IR & Global Finance Christophe Weber - President & CEO Andrew Plump - President, Research & Development and Director Constantine Saroukos - CFO & Director Masato Iwasaki - President, Japan Pharma Business Unit & Director Julie Kim - President, Plasma-Derived Therapies Business Unit Ramona Sequeira - President, US Business Unit & Global Portfolio Commer ...